European seizure data reveals falsified Melanotan II and growth hormone trafficked alongside antibiotics
Background
The trafficking of falsified and counterfeit pharmaceuticals poses a significant public health risk. While much attention has been paid to lifestyle drugs like erectile dysfunction medication, the market for other substances, such as antibiotics and injectable biopharmaceuticals (peptides and proteins), is less understood. The unmonitored use of falsified antibiotics contributes to the global crisis of antimicrobial resistance and can obscure sources of infection from health agencies. Similarly, unregulated biopharmaceuticals present direct health risks due to lack of quality control, incorrect labeling, potential for contamination, and the presence of unlicensed or unknown active ingredients.
Study Design
This study, named 'Operation Resistance', analyzed data from 'Operation Pangea 7', an international week of action against pharmaceutical crime in 2014. The researchers requested that national agencies in 12 European countries (Belgium, Cyprus, Czech Republic, Denmark, France, the Netherlands, Portugal, Sweden, Spain, UK, Norway, Switzerland) specifically search for and report on seizures of falsified antibiotics and injectable biopharmaceuticals. The study provides a snapshot of the types and quantities of these drugs seized as they entered Europe.
Results
The participating countries reported seizing a total of approximately 21,000 dose units of falsified antibiotics, most of which were unlicensed versions of common antibiotic drugs. While the abstract notes that 'very few' falsified biopharmaceutical injectables were reported during this specific study week, the ones that were identified are significant. Laboratory analysis of seized injectables confirmed the presence of human growth hormone, sermorelin, and melanotan II. Some seized products contained no active ingredients at all.
The average shipment size for both antibiotics and biopharmaceuticals seemed too large for personal use, indicating that a substantial portion was likely intended for resale within Europe. This suggests an organized illicit supply chain beyond individual importation for personal use.
Key Findings
- A total of ~21,000 dose units of falsified antibiotics were seized in 12 European countries during Pangea 7 (2014).
- Falsified biopharmaceutical injectables seized included human growth hormone, sermorelin, and melanotan II.
- Some seized injectables were found to contain no active ingredients.
- Shipment sizes were often too large for personal use, suggesting intent to resell.
Why It Matters
This report highlights that the illicit drug market in Europe extends beyond commonly recognized categories like ED drugs. For users of peptides and other biopharmaceuticals, this is a stark reminder of the risks associated with sourcing from unregulated channels. The seized products may contain the wrong substance, no substance, or harmful contaminants. The fact that peptides like Melanotan II and sermorelin were found demonstrates a demand and an illicit supply chain for these specific compounds. This reinforces the importance of sourcing from reputable providers and raises awareness for healthcare professionals that patients may be using potentially dangerous, falsified injectable products for performance enhancement or cosmetic purposes, creating unknown health risks.
